Fenfluramine Hydrochloride

盐酸芬氟拉明

Report date: 2026/05/21 20:00:22

Base Information

Drug NameFenfluramine Hydrochloride
Drug Alias Name芬氯拉明fenfluraminum hydrochloridumFinteplaZX-008AHR-3002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsCDKL5 deficiency disorderCocaine-Related DisordersObesity +[13] 
Global Approved IndicationsObesitySeizuresLennox Gastaut Syndrome +[4] 
Approved Indications in ChinaObesity
Original Approved Country/TerritoryMainland China
Original Approved Date1984/05/03
Country/TerritoryBelgiumCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZogenix
China Registration ClassN/A

Develop Information

Active CompaniesZogenixUcb IncUcb Japan Co Ltd +[7] 
Inactive CompaniesNational Institute On Drug AbuseNational Heart, Lung, And Blood Institute (Nhlbi)State Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry +[4] 
Active IndicationsCDKL5 deficiency disorderSeizuresSpasm +[9] 
Inactive IndicationsCocaine-Related DisordersObesityVascular Diseases +[4] 

Other Information

ATC CodeA08AA02
Related LinksWikipediaDrugBankKEGG